CVRx, Inc. (CVRX): who owns it and who trades it
As of Nov 16, 2026, CVRX insiders reported 10 open-market sales worth $381K and 3 purchases worth $377K in the last 12 months, with 34% of the sale value made under pre-set 10b5-1 plans. The largest seller was Johnson & Johnson Innovation - JJDC, Inc. (10% owner), with $160K. 3 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling CVRx
From the latest filingsOverall: more buying than selling. Famous investors mostly bought. Funds and insiders were close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns CVRX
88 funds and institutions reported CVRX shares worth $78.9M at the end of Q2 2026, about 58% of the company. The largest holder is Johnson & Johnson with 15.2%.
Funds and institutions (13F) 58%Everyone else 42%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| Johnson & Johnson | 4.02M | 15.17% | $20.7M | No change |
| NEA Management Company, LLC | 1.95M | 7.37% | $10M | -4% |
| BlackRock, Inc. | 1.25M | 4.69% | $6.4M | +21% |
| Royal Bank of Canada | 1.23M | 4.65% | $6.3M | +74% |
| GSK plc | 1.01M | 3.80% | $5.2M | No change |
| Vanguard Capital Management LLC | 910,576 | 3.43% | $4.7M | -0% |
| Silvercrest Asset Management Group LLC | 878,109 | 3.31% | $4.5M | +54% |
| Geode Capital Management, LLC | 440,786 | 1.66% | $2.3M | +3% |
| PFM Health Sciences, LP | 369,572 | 1.39% | $1.9M | New |
| State Street Corp | 366,352 | 1.38% | $1.9M | +5% |
| Renaissance Technologies LLC | 230,000 | 0.87% | $1.2M | +1092% |
| UBS Group AG | 224,233 | 0.85% | $1.2M | +116% |
| Tudor Investment Corp Et Al | 205,684 | 0.78% | $1.1M | +4% |
| Goldman Sachs Group Inc | 149,509 | 0.56% | $768K | -26% |
| Morgan Stanley | 144,977 | 0.55% | $745K | +4% |
| Kestra Advisory Services, LLC | 132,400 | 0.50% | $681K | +176% |
| Two Sigma Investments, LP | 132,398 | 0.50% | $681K | +16% |
| Vanguard Fiduciary Trust Co | 128,955 | 0.49% | $663K | +1% |
| Dimensional Fund Advisors LP | 127,971 | 0.48% | $660K | +143% |
| Northern Trust Corp | 124,767 | 0.47% | $641K | -17% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, CVRX insiders reported $377K of open-market purchases and $381K of sales. 34% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | Brent Binkowski | CHIEF OPERATING OFFICER | Purchase | 26,223 | $2.91 | $76.3K | Form 4 |
| Aug 12, 2026 | Brent Binkowski | CHIEF OPERATING OFFICER | Sale plan | 1,309 | $2.55 | $3.3K | Form 4 |
| Mar 2, 2026 | Philip B. Adamson | Chief Medical Officer | Sale plan | 1,262 | $7.90 | $10K | Form 4 |
| Mar 2, 2026 | Kevin Hykes | CEO | Sale plan | 7,763 | $7.90 | $61.3K | Form 4 |
| Mar 2, 2026 | Paul Verrastro | CHIEF MKTG & STRAT OFFIC | Sale plan | 1,284 | $7.90 | $10.1K | Form 4 |
| Mar 2, 2026 | Jared Oasheim | CFO | Sale plan | 1,744 | $7.90 | $13.8K | Form 4 |
| Mar 2, 2026 | Robert Allen John | Chief Revenue Officer | Sale plan | 3,964 | $7.90 | $31.3K | Form 4 |
| Feb 20, 2026 | Mudit K. Jain | Director | Purchase | 46,800 | $6.36 | $298K | Form 4 |
| Feb 18, 2026 | Mudit K. Jain | Director | Purchase | 600 | $4.64 | $2.8K | Form 4 |
| Nov 26, 2025 | & Johnson Johnson +1 | 10% owner | Sale | 6,337 | $10.03 | $63.6K | Form 4 |
| Nov 25, 2025 | Johnson & Johnson Innovation - JJDC, Inc. +1 | 10% owner | Sale | 16,000 | $10.03 | $160K | Form 4 |
| Nov 24, 2025 | & Johnson Johnson +1 | 10% owner | Sale | 2,200 | $10.06 | $22.1K | Form 4 |
| Nov 21, 2025 | & Johnson Johnson +1 | 10% owner | Sale | 500 | $10.00 | $5K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Mudit K. Jain | Director | $300K | – | Feb 20, 2026 |
| Johnson & Johnson Innovation - JJDC, Inc. | 10% owner | – | $160K | Nov 25, 2025 |
| & Johnson Johnson | 10% owner | – | $90.7K | Nov 26, 2025 |
| Brent Binkowski | CHIEF OPERATING OFFICER | $76.3K | $3.3K | Aug 13, 2026 |
| Kevin Hykes | PRES & CEO, Director | – | $61.3K | Mar 2, 2026 |
| Robert Allen John | Chief Revenue Officer | – | $31.3K | Mar 2, 2026 |
| Jared Oasheim | CHIEF FINANCIAL OFFICER | – | $13.8K | Mar 2, 2026 |
| Paul Verrastro | CHIEF MKTG & STRAT OFFICER | – | $10.1K | Mar 2, 2026 |
| Philip B. Adamson | Chief Medical Officer | – | $10K | Mar 2, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
CVRX short interest
Moderate short interest. 6.4% of CVRX shares are sold short: about 1 share in 16. Over the last 12 reports the number of shares short went down 5%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 1.82M CVRX shares were sold short, 6.4% of the shares outstanding, down 14.9% from the report before. At the average daily volume of 341,489 shares, buying them all back would take about 5.3 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 1.82M | 6.39% | -15% | 341,489 | 5.3 |
| Oct 15, 2026 | 2.14M | 8.02% | +8% | 691,069 | 3.1 |
| Sep 30, 2026 | 1.98M | 7.44% | +21% | 826,036 | 2.4 |
| Sep 15, 2026 | 1.64M | 6.17% | -17% | 631,100 | 2.6 |
| Aug 31, 2026 | 1.97M | 7.39% | -16% | 815,056 | 2.4 |
| Aug 14, 2026 | 2.36M | 8.85% | +17% | 2.54M | 1.0 |
| Jul 31, 2026 | 2.01M | 7.54% | +4% | 253,282 | 7.9 |
| Jul 15, 2026 | 1.93M | 7.26% | +5% | 216,519 | 8.9 |
| Jun 30, 2026 | 1.84M | 6.93% | +5% | 343,340 | 5.4 |
| Jun 15, 2026 | 1.76M | 6.62% | -10% | 289,775 | 6.1 |
| May 29, 2026 | 1.94M | 7.33% | +2% | 260,457 | 7.5 |
| May 15, 2026 | 1.91M | 7.18% | +9% | 474,149 | 4.0 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
CVRx company events
CVRx filed 12 reports on Form 8-K in the last 12 months, 4 of them about an important change (leadership). The latest was on Nov 5, 2026.
- Nov 5, 2026ResultsReleased financial results. Filing
- Sep 21, 2026LeadershipCVRx, Inc. announced that its Board of Directors appointed John Landry as Chief Financial Officer. Filing
- Aug 11, 2026LeadershipThe employment of Robert John, the Chief Revenue Officer of CVRx, Inc., terminated effective immediately, under circumstances entitling him to severance pay and benefits under his employment agreement, subject to the conditions therein. Filing
- Aug 6, 2026ResultsReleased financial results. Filing
- Jun 9, 2026LeadershipJared Oasheim, the Chief Financial Officer of CVRx, Inc., gave notice of his intention to resign from the Company to pursue other professional opportunities. Filing
- Jun 3, 2026VoteReported shareholder vote results. Filing
- May 11, 2026ResultsReleased financial results. Filing
- Apr 13, 2026AnnouncementAs disclosed above, on April 13, 2026, the Company issued a press release announcing certain preliminary financial results for the first quarter ended March 31, 2026, and provided information about reimbursements and its BENEFIT-HF trial . First Quarter 2026 Total revenue for the first quarter of… Filing
- Mar 3, 2026LeadershipAt the same time as the Compensation Committee of the Board of Directors of CVRx, Inc. approved annual equity awards for the Company’s executive officers, the Committee also approved an incremental equity award in the form of performance stock units specific to a cumulative revenue goal for the… Filing
- Feb 12, 2026ResultsReleased financial results. Filing
- Jan 12, 2026AgreementCVRx, Inc. entered into an Open Market Sale Agreement SM with Jefferies LLC. Filing
- Jan 12, 2026AgreementCVRx, Inc. entered into an amendment to its existing Loan and Security Agreement dated October 31, 2022, as previously amended on March 13, 2023 (as amended, the “Loan Agreement”), among the Company, Innovatus Life Sciences Fund I, LP, as the collateral agent and a lender, and the other lenders… Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
CVRx financials
Famous investors that hold CVRX
3 of the 50 well-known investors we track reported holding CVRX in their latest 13F filing. The largest position is Ken Griffin's, worth $1.1M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ken Griffin · Citadel Advisors | Q3 2026 | 652,362 | $1.1M | 0.0% | +726% |
| Jim Simons · Renaissance Technologies | Q3 2026 | 435,400 | $762K | 0.0% | +89% |
| Paul Tudor Jones · Tudor Investment Corp | Q3 2026 | 208,058 | $364K | 0.0% | +1% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named CVRX in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Oct 2, 2026 | Chernett Jorey | 13D/A | 0.6% |
| Oct 2, 2026 | Chernett Jorey | 13D/A | 0.6% |
Questions about CVRx, Inc. (CVRX) stock
Who owns the most CVRX stock?
The largest reported owner of CVRx, Inc. (CVRX) is Johnson & Johnson, with 15.2% of the company. In total, 88 funds and institutions reported holding CVRX at the end of Q2 2026, together about 58% of the shares. See the largest owners.
Are CVRX insiders buying or selling?
In the last 12 months, CVRX insiders reported 3 open-market purchases worth $377K and 10 sales worth $381K. The latest trade was on Aug 13, 2026. See every trade.
What is the short interest in CVRX?
As of Oct 30, 2026, 1.82M CVRX shares were sold short, 6.4% of the shares outstanding, down 14.9% from the report before. At the average daily volume of 341,489 shares, buying them all back would take about 5.3 trading days (days to cover). See the history.
Which famous investors hold CVRX?
3 of the 50 well-known investors we track reported CVRX in their latest 13F filing, including Ken Griffin, Jim Simons, Paul Tudor Jones. The largest position is worth $1.1M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.